Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACYW versus Menveo in healthy infants and toddlers with routine pediatric vaccines
2017-004977-15Phase 3
- Sponsor
- Sanofi
- Start
- Feb 2020
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of Meningococcal ACWY conjugate vaccine and meningococcal A conjugate vaccine in meningococcal disease (2 arms), sponsored by Sanofi. Primary endpoint: Antibody titers against meningococcal serogroups A, C, Y, and W.
02
Drugs
Meningococcal ACWY conjugate vaccinemeningococcal A conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2017-004977-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004977-15.